DrugPatentWatch Database Preview
Profile for Norway Patent: 20100250
US Patent Family Members and Approved Drugs for Norway Patent: 20100250
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Mar 29, 2026 | Novartis | GILENYA | fingolimod |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |